Source: Annual Congress 2012 - Acute exacerbation in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Søyseth, R. Bhatnagar, N. Holmedahl, G. Einvik (Lørenskog, Hakadal, Norway). Acute exacerbation of COPD is associated with three-fold elevation of cardiac troponin T. Eur Respir J 2012; 40: Suppl. 56, 4300

Member's Comments

No comment yet.

Related content which might interest you: Cardiac troponin I elevation in the exacerbations of severe COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Predictors of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Troponin T elevation and one year mortality after acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD Year: 2009 Increased prevalence of elevated high-sensitivity cardiac troponin T among patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Relationships between elevated cardiac troponin levels in COPD exacerbations and subsequent cardiac investigation and management Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Evaluation of serum troponin level in exacerbation of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005 High-sensitivity cardiac troponin T is associated with increased mortality in patients with stable chronic obstructive pulmonary disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Prognostic value of high troponin levels in acute COPD attack patients with respiratory insufficiency Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Eur Respir J 2008; 31: 563-570 Year: 2008 Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005 Any detectable admission cardiac troponin I level is associated with increased risk of early death following COPD exacerbations Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011 The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Cardiac troponin increases in COPD patients hospitalised for pneumonias as well as exacerbations Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Cardiac troponin T levels increase overnight in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 COPD exacerbation - the search for a respiratory “troponin” Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations Year: 2018 Elevated cardiac troponin predicts 11-year mortality in COPD Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 Exercise induced elevation of high-sensitive troponin T serum levels in patients with pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Copeptin – a marker for differential diagnosis between acute exacerbation of COPD and heart failure in patients with acute dyspnea Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021